Index by author

December 01, 2021; Volume 88,Issue 12

  1. Angelini, Dana

    1. Updated guidelines for immune thrombocytopenic purpura: Expanded management options
      Sherwin DeSouza, MD and Dana Angelini, MD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 664-668; DOI: https://doi.org/10.3949/ccjm.88a.20201

      The aim is to help practitioners decide on inpatient vs outpatient management, thresholds for initiating treatment, and options for second-line treatment in adults.

  2. Arora, Harkesh

    1. COVID-19 vaccine-induced cellulitis and myositis
      Sathishkumar Ramalingam, MD, Harkesh Arora, MD, Susan Lewis, MD, Kulothungan Gunasekaran, MD, Maheswari Muruganandam, MD, Sivakumar Nagaraju, MD and Priyesh Padmanabhan, MD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 648-650; DOI: https://doi.org/10.3949/ccjm.88a.21038

      The day after receiving the second dose of the mRNA vaccine, redness and pain developed at the injection site, eventually involving the whole left arm and shoulder.

  3. Bash, Kathryn

    1. Neuropsychiatric assessment and management of the ICU survivor
      Erin A. Dean, MD, Michelle Biehl, MD, Kathryn Bash, APRN, CNP, Jeremy Weleff, DO and Leopoldo Pozuelo, MD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 669-679; DOI: https://doi.org/10.3949/ccjm.88a.20169

      Post-intensive care syndrome occurs in 50% to 70% of ICU survivors. The authors examine various facets of this syndrome and emphasize the role of post-ICU recovery clinics.

  4. Biehl, Michelle

    1. Neuropsychiatric assessment and management of the ICU survivor
      Erin A. Dean, MD, Michelle Biehl, MD, Kathryn Bash, APRN, CNP, Jeremy Weleff, DO and Leopoldo Pozuelo, MD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 669-679; DOI: https://doi.org/10.3949/ccjm.88a.20169

      Post-intensive care syndrome occurs in 50% to 70% of ICU survivors. The authors examine various facets of this syndrome and emphasize the role of post-ICU recovery clinics.

  5. Carrubba, Aakriti R.

    1. Changing US trends in contraceptive choices
      Suneela Vegunta, MD, FACP, NCMP, Aakriti R. Carrubba, MD and Megan N. Wasson, DO, FACOG
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 689-695; DOI: https://doi.org/10.3949/ccjm.88a.20110

      The history and the pros and cons of depot medroxyprogesterone acetate and long-acting reversible contraceptives are examined.

  6. Dang, Michael

    1. Physician resistance to obesity pharmacotherapy
      Vania Modesto-Lowe, MD, Allison Wick, BS and Michael Dang, BS, MD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 658; DOI: https://doi.org/10.3949/ccjm.88c.12003

  7. Dean, Erin A.

    1. Neuropsychiatric assessment and management of the ICU survivor
      Erin A. Dean, MD, Michelle Biehl, MD, Kathryn Bash, APRN, CNP, Jeremy Weleff, DO and Leopoldo Pozuelo, MD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 669-679; DOI: https://doi.org/10.3949/ccjm.88a.20169

      Post-intensive care syndrome occurs in 50% to 70% of ICU survivors. The authors examine various facets of this syndrome and emphasize the role of post-ICU recovery clinics.

  8. Deguchi, Kentaro

    1. Metronidazole-induced encephalopathy: Symmetrical hyperintensity on imaging
      Hiroki Matsuura, MD, Takashi Katayama, MD and Kentaro Deguchi, MD, PhD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 651-652; DOI: https://doi.org/10.3949/ccjm.88a.21007

      The diagnosis should be based on a combination of the patient’s clinical history, laboratory findings, and imaging results.

  9. Desouza, Sherwin

    1. Updated guidelines for immune thrombocytopenic purpura: Expanded management options
      Sherwin DeSouza, MD and Dana Angelini, MD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 664-668; DOI: https://doi.org/10.3949/ccjm.88a.20201

      The aim is to help practitioners decide on inpatient vs outpatient management, thresholds for initiating treatment, and options for second-line treatment in adults.

  10. Gunasekaran, Kulothungan

    1. COVID-19 vaccine-induced cellulitis and myositis
      Sathishkumar Ramalingam, MD, Harkesh Arora, MD, Susan Lewis, MD, Kulothungan Gunasekaran, MD, Maheswari Muruganandam, MD, Sivakumar Nagaraju, MD and Priyesh Padmanabhan, MD
      Cleveland Clinic Journal of Medicine December 2021, 88 (12) 648-650; DOI: https://doi.org/10.3949/ccjm.88a.21038

      The day after receiving the second dose of the mRNA vaccine, redness and pain developed at the injection site, eventually involving the whole left arm and shoulder.

« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue